800,000 euro subsidy for development of new heart monitoring technology

Professor of Cardiology at Maastricht UMC+ Harry Crijns and his team have secured a subsidy of 800,000 euros. The amount is to be used for the development of a new monitoring system, whereby patients can track their own heartbeat at home. This creates a personal treatment of atrial fibrillation, a common arrhythmia disorder.

Most people go immediately to first aid for this type of complaint. The rhythm is usually restored there with an electric shock. However research shows that the heart rhythm can often recover automatically. Harry Crijns hopes that in the future only people with a permanent arrhythmia will report to the hospital. With new technology to be developed, people with atrial fibrillation can monitor their own heart rhythm. The data is sent to a doctor who can intervene quickly if necessary. Harry Crijns and his team received 800,000 euros for the development of this technology, half made possible by Hartstichting.